Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Income from Continuing Operations (2016 - 2025)

Immucell's Income from Continuing Operations history spans 16 years, with the latest figure at 2849142.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 653.71% year-over-year to 2849142.0; the TTM value through Dec 2025 reached 1040027.0, up 51.78%, while the annual FY2025 figure was 1040027.0, 51.78% up from the prior year.
  • Income from Continuing Operations reached 2849142.0 in Q4 2025 per ICCC's latest filing, down from 139748.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1446983.0 in Q1 2025 to a low of 2849142.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 577167.55, with a median of 548190.5 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: crashed 2349.8% in 2022, then skyrocketed 430.46% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 74134.0 in 2021, then plummeted by 2349.8% to 1667866.0 in 2022, then surged by 31.66% to 1139831.0 in 2023, then skyrocketed by 145.14% to 514555.0 in 2024, then plummeted by 653.71% to 2849142.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Income from Continuing Operations are 2849142.0 (Q4 2025), 139748.0 (Q3 2025), and 501880.0 (Q2 2025).